Alignment Healthcare

Alignment Healthcare, Inc. operates as holding company. The company offers consumer-centric platform that delivers customized health care solutions to seniors and those who need it most, the chronically ill and frail, through its Medicare Advantage plans. The firm offers health plan options through Alignment Health Plan, and also partners with select health plans to help deliver better benefits at lower costs. The company was founded in 2013 and is headquartered Orange, CA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Alignment Healthcare reports strong Q4 results, eyes growth opportunities

Alignment Healthcare's Q4 2022 performance showcased revenue growth and membership expansion, underpinned by successful programs and strategic pillars. While challenges in profitability persist, opportunities in program optimization and strategic focus areas offer avenues for future growth.

Alignment Healthcare reports robust Q1 growth and strategic positioning

Alignment Healthcare's strong Q1 performance and strategic positioning under new CMS changes reflect growth potential. Challenges lie in achieving profitability targets and managing potential M&A opportunities cautiously. The company's focus on member retention and operational efficiency bodes well for future success.

Alignment Healthcare reports robust Q2 results, eyes shared risk growth

Alignment Healthcare's Q2 performance was strong, with revenue growth and membership increase. The company is addressing challenges in profitability and market variability while focusing on enhancing broker relationships and shared risk business. Opportunities exist in targeted market expansions and product strategy improvements.

Alignment Healthcare surpasses Q3 expectations, eyes growth amid challenges

Alignment Healthcare exceeded Q3 expectations with strong revenue and membership growth, showcasing momentum and strategic positioning for future success.
Despite challenges related to Union dynamics and potential Medicare rate fluctuations, the company remains confident in achieving its guidance and aims for continued growth.
By leveraging strengths like partnerships, innovative initiatives, and a focus on member experience, Alignment Healthcare is well-positioned for growth and financial stability.

Alignment Healthcare reports robust Q4 growth amidst reimbursement challenges

Alignment Healthcare demonstrated strong financial performance in Q4 2023, despite facing reimbursement challenges and EBITDA losses.
The company's focus on brand recognition, care model portability, and unique risk models in California positions them well for growth and profitability.
Investments in technology, membership growth projections, and positive regulatory changes offer opportunities for Alignment Healthcare to enhance operational efficiency and market position.

Alignment Healthcare reports robust Q1 growth, eyes 20% membership increase

Alignment Healthcare's Q1 2024 earnings call highlighted strong growth in membership and revenue, exceeding expectations in adjusted EBITDA. The company is confident in its ability to grow membership by 20% in 2025, leveraging its unique capabilities and operational model. Challenges in inpatient costs and care navigation require continuous improvement efforts.

Alignment Healthcare reports strong Q2 growth and targets market expansion

Alignment Healthcare demonstrated robust growth in membership, revenue, and profitability in Q2 2024, positioning itself as a key player in the MA plans sector.
The company's strategic focus on profitable growth, market share expansion, and quality service delivery underscores its commitment to sustainable success.
While facing challenges in achieving profitability targets, Alignment Healthcare remains optimistic about its growth prospects and market positioning.

Alignment Healthcare excels in Q3, poised for sustained growth

Alignment Healthcare's Q3 2024 performance reflects strong growth, profitability, and strategic positioning in the Medicare Advantage sector.
With a focus on maintaining high plan ratings, investing in key markets, and enhancing healthcare capabilities, Alignment is poised for continued success.
While challenges in meeting financial expectations and industry dynamics persist, Alignment's strengths and opportunities position it for sustainable growth and competitiveness.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Alignment Healthcare, Inc. operates as a holding company. The company offers a consumer-centric platform that delivers customized health care solutions to seniors and those who need it most, the chronically ill and frail, through its Medicare Advantage plans. The firm offers health plan options through Alignment Health Plan, and partners with select health plans to help deliver better benefits at lower costs. The company was founded by John E. Kao in 2013 and is headquartered Orange, CA.

Alignment Healthcare to extend its Medicare Advantage prescription drug plans to Alameda, Fresno and Madera counties in 2023, pending regulatory approval Alignment Healthcare to extend its Medicare Advantage prescription drug plans to Alameda, Fresno and Madera counties in 2023, pending regulatory approval

Alignment Health Plan to Expand Northern and Central California Service Area, Making Award-Winning Plan Benefits Available to 82% of Medicare-Eligible Adults Statewide

ORANGE, Calif., July 14, 2022 (GLOBE NEWSWIRE) -- Alignment Healthcare  (NASDAQ: ALHC), a tech-enabled Medicare Advantage company, today announced more details of its expansion into Texas, extending its award-winning Medicare Advantage plans and highly rated care model to about 140,000 Medicare-eligible adults in El Paso and Hudspeth counties in 2023, pending regulatory approval from the Centers for Medicare & Medicaid Services (CMS).1

Alignment Healthcare to Enter Texas in 2023, Introducing Its Award-Winning Medicare Advantage Plans to Medicare-Eligible Adults in El Paso, Hudspeth Counties

ORANGE, Calif., July 12, 2022 (GLOBE NEWSWIRE) -- Alignment Healthcare  (NASDAQ: ALHC), a tech-enabled Medicare Advantage company, will begin offering Alignment Health Plan benefit packages for the first time in Florida in 2023, reaching nearly 500,000 Medicare-eligible adults across four counties in the state, pending regulatory approval from the Centers for Medicare & Medicaid Services (CMS).1

Alignment Healthcare to Introduce Award-Winning Medicare Advantage Plans with its Unique Care Model to Half a Million Medicare-Eligible Adults in Florida

ORANGE, Calif., July 05, 2022 (GLOBE NEWSWIRE) -- Alignment Healthcare (NASDAQ: ALHC), a tech-enabled Medicare Advantage company, today announced that Randall Fitzpatrick has joined its leadership team as senior vice president of product. In this newly created role at Alignment, reporting to Dawn Maroney, the company's president, markets, Fitzpatrick will lead the development of the company's Medicare Advantage product design.

Alignment Healthcare Welcomes Randall Fitzpatrick, Formerly of Optum, as Senior Vice President of Product

Medicare Advantage company to also introduce its award-winning health plans to new counties within Arizona, California, Nevada and North Carolina, pending approval Medicare Advantage company to also introduce its award-winning health plans to new counties within Arizona, California, Nevada and North Carolina, pending approval

Alignment Healthcare to Expand to Florida and Texas to Reach 8.2 Million Medicare-eligible Adults across Six States

Alignment Healthcare is expanding Medicare Advantage into Florida and Texas for 2023.

Alignment Healthcare Will Expand Medicare Advantage To Lucrative Florida And Texas Markets For 2023

ORANGE, Calif., June 02, 2022 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (Nasdaq: ALHC), a tech-enabled Medicare Advantage company, today announced that John Kao, founder and CEO, and Thomas Freeman, chief financial officer, will participate in the following investor conferences:

Alignment Healthcare to Participate in the William Blair Annual Growth Stock Conference and Goldman Sachs Annual Global Healthcare Conference

Award celebrates ambitious pioneers tackling our biggest challenges Award celebrates ambitious pioneers tackling our biggest challenges

Alignment Healthcare Founder and CEO John Kao Named Entrepreneur Of The Year® 2022 Pacific Southwest Award Finalist

Alignment Healthcare, Inc. (NASDAQ:ALHC ) Q1 2022 Earnings Conference Call May 5, 2022 5:30 PM ET Company Participants John Kao – Founder and Chief Executive Officer Thomas Freeman – Chief Financial Officer Conference Call Participants Ryan Daniels – William Blair Ricky Goldwasser – Morgan Stanley Jeff Garro – Piper Sandler Cal Sternick – JPMorgan Nathan Rich – Goldman Sachs Kevin Fischbeck – Bank of America Kevin Caliendo – Wells Fargo Operator Welcome to the Alignment Healthcare First Quarter 2022 Earnings Conference Call. [Operator Instructions] Please note, this event is being recorded.

Alignment Healthcare's (ALHC) CEO John Kao on Q1 2022 Results - Earnings Call Transcript

ORANGE, Calif., May 05, 2022 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (“Alignment Healthcare” or the “Company”) (Nasdaq: ALHC), a tech-enabled Medicare Advantage company, today reported financial results for its first quarter ended March 31, 2022.

Alignment Healthcare Reports First Quarter 2022 Financial Results; Beats Guidance Across Four Key KPIs; Continues Sustainable Growth

Alignment Healthcare (ALHC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Will Alignment Healthcare (ALHC) Report Negative Earnings Next Week? What You Should Know

ORANGE, Calif., April 21, 2022 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (“Alignment Healthcare” or the “Company”) (Nasdaq: ALHC), a tech-enabled Medicare Advantage company, will release its first quarter 2022 financial results on Thursday, May 5, 2022, after market close. In conjunction, the company will host a conference call to review the results at 5:30 p.m. EDT.

Alignment Healthcare to Announce First Quarter 2022 Financial Results and Host Conference Call Thursday, May 5, 2022

Investment in leadership team to support company as it scales to serve more seniors across U.S. Investment in leadership team to support company as it scales to serve more seniors across U.S.

Alignment Healthcare Expands Roles for Executives Dawn Maroney and Dinesh Kumar to Support Market Expansion

ORANGE, Calif., March 30, 2022 (GLOBE NEWSWIRE) -- Alignment Healthcare (NASDAQ: ALHC), a tech-enabled Medicare Advantage company, marked one year of being publicly listed. With the popular growth of Medicare Advantage, Alignment is emerging as an innovator, continuing to scale its care delivery model with its proprietary AVA® technology, programs tailored to members' needs and value of treating every member like family. Alignment's first trading day was March 26, 2021.

Alignment Healthcare Celebrates One Year as a Public Company with Significant Revenue, Product and Membership Growth, Doubled Geographic Footprint

ironSource Ltd

Codiak Biosciences

Lyell Immunopharma

Sonendo

While most of Wall Street focuses on large-cap and mega-cap stocks, as they provide a degree of safety and liquidity, many investors are limited in the number of shares they can buy.

Goldman Sachs Has 5 Buy-Rated Stocks Under $10 With 100% to 700% Upside Potential

Alignment Healthcare, Inc. (ALHC) CEO John Kao on Q4 2021 Results - Earnings Call Transcript

ORANGE, Calif., March 03, 2022 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (“Alignment Healthcare” or the “Company”) (Nasdaq: ALHC), a tech-enabled Medicare Advantage company, today reported financial results for its fourth quarter and full year ended Dec. 31, 2021.

Alignment Healthcare Reports Fourth Quarter and Full-Year 2021 Financial Results

Illumina

SAN DIEGO, Feb. 10, 2022 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced its financial results for the fourth quarter and fiscal year 2021, which include the consolidated financial results of GRAIL. Fourth quarter consolidated results: Revenue of $1,198 million, a 26% increase compared to the prior year period GAAP net income for the quarter of $112 million, or $0.71 per diluted share, compared to $257 million, or $1.75 per diluted share, for the prior year period Non-GAAP net income for the quarter of $117 million, or $0.75 per diluted share, compared to $179 million, or $1.22 per diluted share, for the prior year period (see the "Consolidated Reconciliation Between GAAP and Non-GAAP Net Income" table for a reconciliation of these GAAP and non-GAAP financial measures) Cash flow from operations of $282 million compared to $406 million in the prior year period Free cash flow (cash flow from operations less capital expenditures) of $212 million for the quarter compared to $344 million in the prior year period "We are seeing strength across our business as a growing number of patients around the world are accessing the life-saving benefits of genomics, from oncology therapy selection to genetic disease testing and pathogen surveillance," said Francis deSouza, Chief Executive Officer.

Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2021

Anthem

CVS Health

Intuitive Surgical

Could health care stocks be back in focus amid market volatility?

Top 4 Health Care Stocks To Watch In February 2022

Medicare Advantage company reported 2021 fourth quarter inpatient utilization about 5 percent lower than expected Medicare Advantage company reported 2021 fourth quarter inpatient utilization about 5 percent lower than expected

Alignment Healthcare Continues to Pave the Way for Sustainable Growth with Unique Payvidor Model

ORANGE, Calif., Jan. 03, 2022 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (“Alignment Healthcare” or the “Company”) (Nasdaq: ALHC), a tech-enabled Medicare Advantage company, today announced that John Kao, founder and CEO, and Thomas Freeman, chief financial officer, will participate in the 40th Annual J.P. Morgan Healthcare Conference including a presentation on Wednesday, Jan. 12, 2022, at 4:30 p.m. E.T. An audio-only replay of the presentation will be available at https://ir.alignmenthealthcare.com/.

Alignment Healthcare To Participate in Upcoming J.P. Morgan Healthcare Conference

ORANGE, Calif., Dec. 27, 2021 (GLOBE NEWSWIRE) -- Alignment Healthcare (NASDAQ: ALHC), a tech-enabled Medicare Advantage company, today announced the appointment of Jody Bilney and Yon Yoon Jorden to its Board of Directors, effective Jan. 1, 2022.

Alignment Healthcare Appoints Jody Bilney and Yon Yoon Jorden to its Board of Directors

MENLO PARK, Calif.--(BUSINESS WIRE)--GRAIL announces partnership with Alignment Health Plan as first Medicare Advantage Plan to offer Galleri® multi-cancer early detection blood test.

GRAIL Announces Partnership with Alignment Health Plan as First Medicare Advantage Plan to Offer Galleri® Multi-Cancer Early Detection Blood Test

ORANGE, Calif., Nov. 23, 2021 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (“Alignment Healthcare” or the “Company”), a mission-based, tech-enabled Medicare Advantage company, today announced the closing of its previously announced underwritten public offering of 9,200,000 shares of its common stock by certain selling stockholders at $21.00 per share, including the exercise in full of the underwriters' option to purchase 1,200,000 additional shares of common stock at the public offering price, less underwriting discounts and commissions. The Company will not receive any of the proceeds from the sale of the shares of its common stock by the selling stockholders, and the selling stockholders will bear the costs associated with the sale of such shares, including underwriting discounts and commissions.

Alignment Healthcare Announces Closing of Secondary Offering

ORANGE, Calif., Nov. 22, 2021 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (“Alignment Healthcare” or the “Company”) (Nasdaq: ALHC), a mission-based, tech-enabled Medicare Advantage company, today announced that John Kao, chief executive officer, and Thomas Freeman, chief financial officer, will participate in the Piper Sandler 33rd Annual Healthcare Conference including a fireside chat on Wednesday, Dec. 1, 2021, at 11:00 a.m. E.T. The webcast link will be available at https://ir.alignmenthealthcare.com/.

News for Alignment Healthcare Stock (ALHC)